Webcasts
>All
Nanoparticles for Drug Delivery
January 26th 2022On Demand Webcast Nanoparticles have unique properties that are manipulated to create novel solutions, such as innovative drug delivery systems seen in today’s Covid-19 mRNA vaccines. This webinar explores the analytical techniques used for nanoparticle characterization and its growing significance in drug delivery systems.
Introduction to High Resolution Integrated Weighing
January 18th 2022Tuesday, 1/18/22 at 11am EST | 8am PST | 5pm CET | 4pm GMT In this presentation we look at the products available to support projects where high resolution weight determination is essential. We will also explain what is important when designing a system that requires an integrated weighing solution and the various factors that can influence the performance and final results.
Why Biotech and Pharma Need GxP for their Digital Transformation Projects Now
December 20th 2021Monday December 20, 2021 at 11am EST | 10am CST | 8am PST Pharmaceutical manufacturers are under increasing pressure to fast-track technological innovation while remaining compliant. What are the correct steps to reaching operational intelligence with end-to-end data integrity?
Meet the Modern Lab. A Digital Journey with Scitara’s Scientific Integration Platform™.
December 9th 2021Thursday December 9th, 2021 at 11am EST | 10am CST | 8am PST Meet the Modern Lab. Scitara’s Chief Technology Officer Geoff Gerhardt,PhD, and Head of Product Management Dave Levy, discuss how the Scientific Integration Platform, and its foundational technology, Digital Lab Exchange, overcome the pharma industry’s most long-standing obstacles. With end-to-end connectivity, automation, and ability to manage an increasing volume of complex data, Dave and Geoff offer insight into how Scitara is delivering an exciting foundation for digital transformation. Scitara is developing the mechanisms that will make it relatively straightforward to harness the full value of data, and that means finding, analyzing, extracting and, if necessary, transforming data into a format required by the platforms to which it is transferred. Complete connectivity and retention of context flow will mean labs can push and retrieve contextualized insight into, and out of, data lakes, which can then be better mined and interrogated.
Drug Delivery Devices for Net Zero Emissions: A Pharma Supply Chain Collaboration
December 8th 2021Wednesday, December 8, 2021 at 10am EST | 7am PST | 4pm CET | 3pm GMT How can the pharma packaging supply chain collaborate to make a significant contribution to GHG emissions reduction goals? Join the webcast on December 8th to learn what a net zero emission concept for pharmaceutical manufacturing and supply chain would look like, and the steps necessary to achieve it.
From Lab to Commercial: Fully Integrated Solutions for Dry Powder Inhalation
December 2nd 2021Thursday, December 2, 2021 at 4:00pm GMT | 11:00 am EDT What to look for to bring an inhaled medicine from feasibility study to commercial product, from a particle engineering, formulation, drug delivery and analytical characterization perspective. General rules will be supported through case studies
Peptide Formulation: Initial Clinical Development, Final Dosage Forms and Life Cycle Management
November 30th 2021**Tuesday, Nov. 30, 2021 at 2pm EST | 1pm CST | 11am PST*** Formulation options for peptides in early development versus strategies for final dosage for design, keeping all options open. Peptide formulation strategies for rapid entry to the clinic. *** On demand available after final airing until November 30, 2022.***
Assessing the safety of extractables and leachables for drug products: when and how?
November 17th 2021**Wednesday, November 17, 2021 at 11am EST, 10am CST, 8am PST*** TE&L examples are presented for which the critical toxicological endpoints are discussed and evaluated by means of various methods, in terms of deriving appropriate safety limits. *** On demand available after final airing until November 17, 2022.***
Antibody Products in the Marketplace – Past, Present and Future Growth Drivers
October 27th 2021Wednesday October 27th, 2021 at 10am EDT | 7am PDT | 3pm BST | 4pm CEST Antibody products have evolved to be the cornerstone of the biopharmaceutical market and are a driving force in the pharmaceutical landscape. A variety of tools and technologies have contributed to the success and unrivaled growth of antibody products, learn how current and novel technologies may impact antibody product growth in the coming decades.
Analytical-Scale Prep, Semi-Prep, Process Scale Preparative Chromatography: To Infinity and Beyond!
October 26th 2021Tuesday, October 26, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST Are you planning to turn your analytical HPLC method into a purification method? Are you converting your analytical-scale purification method to semi-prep or production scale? Learn how to set appropriate purification goals for purity, yield and throughput and what type of equipment will best fit your application.
Container Closure Integrity of Product Requiring Deep Cold Storage
October 21st 2021Thursday, October 21, 2021 at 4pm CEST |10am EDT| 7am PDT| 3pm BST Protect not only your valuable product but also public health by ensuring correct storage choices. Gain insight into the effects of deep cold storage and a holistic approach to ensure Container Closure Integrity of sterile pharmaceuticals.
Structured Formulation Development of Poorly Soluble Drugs Guided by a Virtual Formulation Assistant
October 19th 2021Tuesday, October 19, 2021 at 10am EDT| 7am PDT| 3pm BST| 4pm CEST Join this webcast on digital tools for guiding the formulation development of poorly soluble drugs to learn about recent features of BASF’s virtual formulation assistant. Explore how to identify the most suitable formulation approach for your active ingredient.
The Ever-Changing World of Extractables and Leachables: Lessons learned and future challenges
October 4th 2021October 4, 2021 at 3pm BST | 10am EST | 4pm CEST Join global industry and regulatory experts as they discuss current hot topics in extractables and leachables (E&L) testing for pharmaceuticals, biopharmaceuticals and medical devices.
Hit-to-Lead Optimization Strategy In Drug Discovery
September 30th 2021Thursday, September 30, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST In-vitro biochemical assays make the high-throughput screening of large compound libraries possible; however, without a strong hit-to-lead process, time and money are often wasted seeking out the most promising starting points. Register for this webinar to learn best practices for triaging hits and focusing efforts.
Strategies for Effective Patient-Centric Dosage Formulations
September 30th 2021Thursday, September 30, 2021 at 1pm EDT| 12pm CDT| 10am PDT Formulating drugs to facilitate patient adherence, especially for pediatrics, is an ongoing industry challenge. Learn about challenges encountered when formulating drugs with a patient-centric focus, clinical recommendations for pediatric dosage forms, repurposing strategies for formulation development, and technology platforms to optimize oral dosage forms.
Extractables and Leachables: Trends and Future Directions A roundtable discussion
September 28th 2021Tuesday, September 28, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST In the last few years, the issuance of the ISO 10993-18:2020 medical device guidance and several high-profile publications and round-robin studies have resulted in the FDA increasing scrutiny of E&L analyses for both drugs and devices. Join our panel of industry experts to discuss these changes and to learn the direction E&L may take into the future.
Sterilization Techniques for Parenteral Packaging
September 16th 2021Thursday, September 16, 2021 at 10am EDT| 7am PDT| 3pm BST| 4pm CEST Choosing the right sterilization technique for your drug product and its packaging is not always a simple decision. Join the webcast on September 15th to learn about standard sterilization processes, be introduced to newer techniques, and understand how these techniques have been applied to parenteral packaging components.
Technology Forum: The Next Steps for Pharma Manufacturing Efficiency and Effectiveness
September 15th 2021Wednesday, September 15, 2021 at 10am EDTDrug manufacturing demands and increased regulatory oversight are prompting pharmaceutical manufacturers to consider new processes for oral solid dose and aseptically processed drugs. A cross-section of industry experts will offer insight on emerging trends, technologies, and processes in this Technology Forum.
First-in-Human to Commercial: A Microdosing Journey
August 26th 2021Thursday, August 26, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST This webcast will explore the benchmark practices for rapid progression from first-in-human to large-scale commercial manufacture for microdosing API. Micro-dosing at a commercial scale made effortless.
Using Artificial Intelligence in a Digital Twin Strategy
August 23rd 2021Monday, August 23, 2021 at 2pm EDT | 1pm CDT | 11am PDT What do Plato, Roombas, and digital twins for pharma manufacturing have in common? Learn how digital twins, powered by artificial intellingence, can reproduce conditions happening in physical assets to identify and optimize manufacturing process variables, predict outcomes, and empower to bio/pharma companies take action.
Dry Powder Inhalation Delivery of Monoclonal Antibodies
July 22nd 2021Thursday, July 22, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST Local delivery of monoclonal antibodies to the lung is enabled by spray drying to manufacture stable, respirable dry powders. An inhaled formulation of bevacizumab was effective in vivo, reducing tumor burden in a rat model of non-small cell lung cancer.
Meeting Development and Manufacturing Demands for Emerging Therapies
July 21st 2021Wednesday, July 21, 2021 This Technology Forum will explore the current state of commercialization for cell and gene therapies and the patient and physician perspective, as well as the need for technologies, processes, and strategies to ensure competent delivery of these treatments to patients.
